the effect of polyestradiol phosphate ( estradurin ) , a long-acting estrogen preparation given im , was assessed in 24 elderly postmenopausal patients with stage ii or iii primary or recurrent breast carcinoma .
C0071554
polyestradiol phosphate
C0687716
estradurin